XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Collaboration Agreements And Business Development Activities - Ipsen Collaboration Narrative (Details)
$ in Millions, $ in Millions
12 Months Ended
Dec. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
Jan. 01, 2021
USD ($)
Dec. 31, 2016
USD ($)
Dec. 30, 2022
CAD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Milestone payments earned to date $ 489.5        
Collaboration agreement percent of royalty on net sale 3.00%        
Remaining performance obligation $ 73.0        
Collaborative arrangement with Ipsen          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Collaboration period to achieve specified levels of commercial performance 10 years        
Upfront payments       $ 210.0  
Milestone payments earned $ 27.0 $ 112.5 $ 20.0    
Eligible payment from collaboration for development and regulatory milestone achievement under collaborations agreement 19.5        
Maximum amount eligible for commercial milestones under collaborations agreement $ 350.0       $ 26.5
Research and development arrangement performed for others, reimbursement for costs incurred, percent 35.00%        
Commercial sales milestone $ 25.8        
Regulatory milestone 27.0        
Remaining performance obligation $ 35.4        
Collaborative arrangement with Ipsen | Minimum | Final tier          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Percent of royalty on net sale 22.00%        
Collaborative arrangement with Ipsen | Maximum | Final tier          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Percent of royalty on net sale 26.00%        
Collaborative arrangement with Ipsen | Collaboration services revenues          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Cumulative catch-up revenue recognized   $ 43.2